972 filings
Page 10 of 49
10-Q
2021 Q1
ACER
Acer Therapeutics Inc.
Quarterly report
17 May 21
4:19pm
8-K
ACER
Acer Therapeutics Inc.
17 May 21
Acer Therapeutics Reports Q1 2021 Financial Results and Provides Corporate Update
12:00am
DEF 14A
ACER
Acer Therapeutics Inc.
Definitive proxy
16 Apr 21
4:02pm
8-K
ACER
Acer Therapeutics Inc.
2 Apr 21
Regulation FD Disclosure
9:05am
8-K
ACER
Acer Therapeutics Inc.
25 Mar 21
In the United States District Court for the District of Massachusetts
12:00am
8-K
ACER
Acer Therapeutics Inc.
22 Mar 21
Relief to potentially pay Acer up to $36 million and royalties in exchange for net profit share and territory rights
8:31am
EFFECT
ACER
Acer Therapeutics Inc.
15 Mar 21
Notice of effectiveness
12:15am
424B3
ACER
Acer Therapeutics Inc.
12 Mar 21
Prospectus supplement
5:02pm
CORRESP
ACER
Acer Therapeutics Inc.
10 Mar 21
Correspondence with SEC
12:00am
UPLOAD
ACER
Acer Therapeutics Inc.
10 Mar 21
Letter from SEC
12:00am
S-1
ACER
Acer Therapeutics Inc.
IPO registration
3 Mar 21
4:43pm
424B2
ACER
Acer Therapeutics Inc.
3 Mar 21
Prospectus for primary offering
4:40pm
S-8
ACER
Acer Therapeutics Inc.
1 Mar 21
Registration of securities for employees
5:19pm
10-K
2020 FY
ACER
Acer Therapeutics Inc.
Annual report
1 Mar 21
4:46pm
8-K
ACER
Acer Therapeutics Inc.
1 Mar 21
Acer Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
4:07pm
SC 13G/A
Nantahala Capital Management, LLC
12 Feb 21
Acer Therapeutics / Nantahala Capital Management ownership change
3:24pm
8-K
ACER
Acer Therapeutics Inc.
11 Feb 21
Acer Therapeutics Announces Topline Results from its Bioequivalence Trial
9:03am
4
ACER
Acer Therapeutics Inc.
5 Feb 21
Acer Therapeutics / Jefferson E Davis ownership change
4:50pm
3
Jefferson E Davis
5 Feb 21
Acer Therapeutics / Jefferson E Davis ownership change
4:47pm
8-K
ACER
Acer Therapeutics Inc.
25 Jan 21
Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of
8:03am